BioSpace News Archive

Arcellx, Inc. today announced the presentation of new Phase 1 clinical trial data of its CART-ddBCMA for the treatment of patients with relapsed and refractory multiple myeloma.

IGM Biosciences, Inc. today announced its financial results for the third quarter ended September 30, 2021 and provided an update on recent developments.

Adagene Inc. today announced publication of two abstracts featuring preclinical data from its expanding pipeline in advance of the 63rd ASH Annual Meeting & Exposition.

Gilead Sciences, Inc. (Nasdaq: GILD) and Kite today announced that data at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition (December 11-14)

ADC Therapeutics Announces Abstracts to be Presented at the 63rd ASH Annual Meeting

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the release of six abstracts that will be presented at the upcoming 63rd American Society of Hematology (ASH) annual meeting and exposition, to be held December 11 – 14, 2021, virtually and also live at the Georgia World Congress Center in Atlanta, Georgia

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced the upcoming first release of efficacy and safety results from its Phase 3 ALLELE study.

MorphoSys AG announced that new data on approved and clinical-stage therapeutics will be presented during the American Society of Hematology Annual Meeting from December 11-14 in Atlanta, Georgia United States.

Co-Diagnostics, Inc. (Nasdaq: CODX), announced today that its Logix Smart™ SARS-CoV-2 2-Gene multiplex test has been validated according to the United Kingdom Health Security Agency’s (“UKHSA”) Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (“CTDA”) and is available for sale in the UK under the Regulation.

EdiGene to Present Latest Research on A Novel Surface Marker and Migration of Hematopoietic Stem Cell (HSC) That Could Enhance HSC Gene Therapy and HSC Transplantation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition